Abatacept and Anti-Tumor Necrosis Factor Monoclonal Antibodies: Efficacy and Safety Comparisons

被引：0
|
作者：
Schiff, M. [1 ]
Dougados, M. [2 ]
Fleischmann, R. [3 ]
Fay, J. [4 ]
Maldonado, M. [4 ]
机构：
[1] Univ Colorado, Denver, CO 80202 USA
[2] Univ Paris 05, Hop Cochin, Paris, France
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2349
引用
收藏
页码：S1004 / S1004
页数：1
相关论文
共 50 条
  • [1] Abatacept and Anti-Tumor Necrosis Factor Monoclonal Antibodies: Efficacy and Safety Comparisons
    Schiff, Michael
    Dougados, Maxime
    Fleischmann, Roy
    Fay, Jon
    Maldonado, Michael
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1474 - 1474
  • [2] ABATACEPT AND ANTI-TNF MONOCLONAL ANTIBODIES: EFFICACY AND SAFETY COMPARISONS
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 461 - 462
  • [3] Abatacept and anti-TNF monoclonal antibodies: efficacy and safety comparisons
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 103 - 103
  • [4] MODULATION OF THE ANTI-TUMOR ACTIVITY OF TUMOR NECROSIS FACTOR BY MONOCLONAL-ANTIBODIES
    RATHJEN, D
    ASTON, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (04) : 571 - 571
  • [5] Anti-tumor necrosis factor agents in sarcoidosis: A systematic review of efficacy and safety
    Adler, Brandon L.
    Wang, Catherine J.
    Thanh-Lan Bui
    Schilperoort, Hannah M.
    Armstrong, April W.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 1093 - 1104
  • [6] Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor
    Vande Casteele, Niels
    Abreu, Maria T.
    Flier, Sarah
    Papamichael, Konstantinos
    Rieder, Florian
    Silverberg, Mark S.
    Khanna, Reena
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Cheifetz, Adam S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 465 - +
  • [7] Induction of anti-tumor immunity by anti-tumor monoclonal antibodies
    Dhodapkar, Madhav V.
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 635 - 635
  • [8] Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies
    Keystone, Edward C.
    Ware, Carl F.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 : 27 - 39
  • [9] Safety of Anti-Tumor Necrosis Factor Therapies in Arthritis Patients
    Nanau, Radu M.
    Neuman, Manuela G.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (03): : 324 - 361
  • [10] Efficacy and safety of treatment with anti-tumor necrosis factor-α drugs for severe impetigo herpetiformis
    Fukushima, Hidehiko
    Iwata, Yohei
    Arima, Masaru
    Tanaka, Yoshihito
    Sugiura, Kazumitsu
    JOURNAL OF DERMATOLOGY, 2021, 48 (02): : 207 - 210
12345